Avoid Levofloxacin 750 mg IV in patients with known hypersensitivity to levofloxacin or other quinolones. This includes a history of tendonitis or tendon rupture associated with quinolone use.
Exercise caution in patients with epilepsy or a history of seizures. Levofloxacin can lower the seizure threshold; carefully monitor patients at risk.
Patients with myasthenia gravis should use levofloxacin with extreme caution, as it may worsen symptoms. Closely monitor these patients for muscle weakness.
Prolonged QT interval prolongation is a potential risk. Consider avoiding levofloxacin in patients with congenital long QT syndrome or those taking medications known to prolong the QT interval. ECG monitoring might be necessary in susceptible individuals.
Renal impairment necessitates dose adjustment. Always check creatinine clearance before administration and adjust the dose accordingly based on the patient’s renal function.
Hepatic impairment can also affect drug metabolism. Monitor patients with liver disease carefully and consider dose adjustment as needed. Liver function tests are recommended before and during therapy.
Caution is advised during pregnancy and breastfeeding. The risks and benefits must be carefully weighed before prescribing to pregnant or breastfeeding women. Consult current guidelines for detailed recommendations.
Monitor for adverse events, including but not limited to: tendon pain, peripheral neuropathy, CNS effects (dizziness, headache, confusion), and gastrointestinal disturbances. Discontinue treatment if serious adverse reactions occur.
Always consult the current prescribing information for a full list of contraindications and precautions before administering Levofloxacin 750 mg IV.
